lea ament, left, and tamara nunley talk about the care their team provided for helen and robert valenzuela at st. jude medical center in fullerton. (scott smeltzer / staff photographer).
.
advertisement
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
three other countries � spain, czech republic, and slovakia � had also been warned by the eu, but devised sufficient air management plans within the requested time frame..
experts say years of cuts to nhs budgets and staff has led to patients waiting longer for chemotherapy and radiotherapy..
.
we�re at the beginning of a new breakout level of truth. it�s called independent media..
"their serious adverse incident process has been wholly inadequate and what we have heard this week is a damning indictment of the western trust..
.
the statistics i�m quoting reveal a problem on the level of a tsunami sweeping across the whole of america and europe..